Dr Alan Finkel
Australia's Leading Chief Scientist
Dr Finkel commenced as Australia’s Chief Scientist on 25 January 2016. Prior to becoming Chief Scientist, he was the eighth Chancellor of Monash University and the eighth President of the Australian Academy of Technology and Engineering (ATSE). Since commencing as Chief Scientist, Dr Finkel has led a number of national reviews, including serving as the Chair of the Review into the National Electricity Market (“Finkel Review”) and the 2016 National Research Infrastructure Roadmap. He is leading the STEM Industry Partnership Forum for COAG Education Council, and he serves as the Deputy Chair of Innovation and Science Australia. Dr Finkel has an extensive science background as an entrepreneur, engineer, neuroscientist and educator. He was awarded his PhD in electrical engineering from Monash University and worked as a postdoctoral research fellow in neuroscience at the Australian National University. In 1983 he founded Axon Instruments, a California-based, ASX-listed company that made precision scientific instruments used at pharmaceutical companies and universities for the discovery of new medicines. After Axon was sold in 2004, Dr Finkel became a director of the acquiring company, NASDAQ-listed Molecular Devices. In 2006, he focused his career in Australia and undertook a wide range of activities. He led the amalgamation that formed the Florey Neuroscience Institutes; he became Chair of the Australian Centre of Excellence for All-Sky Astrophysics (CAASTRO) and was a director of the ASX-listed diagnostics company Cogstate Limited. He was Executive Chair of the educational software company Stile Education, Chair of Manhattan Investment Group, Chief Technology Officer of Better Place Australia and Chair of Speedpanel Australia.